• Tβ4, Notch/NF-κB, and Ischemic Angiogenesis

  2026-08-20

  The reference study shows that thymosin-β4 promotes endothelial angiogenesis and tissue vascularization in critical limb ischemia through coordinated Notch and NF-κB pathway activity. Its combined use of Tβ4 overexpression, pathway inhibitors, endothelial assays, and mouse tissue analysis provides a useful mechanistic framework for evaluating NF-κB-dependent vascular repair.

• Bafilomycin C1 in Phenotypic Assay Design

  2026-08-20

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that converts lysosomal acidification into a measurable experimental variable. This guide connects V-ATPase biology with deep-learning high-content screening, helping researchers design more interpretable autophagy, toxicity, and cancer biology assays.

• Three-Armed Polyesters for VEGF mRNA Delivery

  2026-08-19

  The reference study introduces arginine- and lysine-functionalized, three-armed biodegradable polyesters as alternatives to conventional nondegradable cationic lipids for VEGF mRNA delivery. Its findings suggest that 3sPA-based lipid nanoparticles combine improved transfection with ROS scavenging and nitric oxide release, linking delivery performance with the biological requirements of critical limb ischemia.

• Direct Mouse Genotyping Kit Plus for SCA3

  2026-08-19

  Build a faster genotype-to-phenotype workflow for SCA3/MJD mouse studies with direct tissue lysis, PCR, and gel-ready products. The workflow is differentiated for transgene confirmation, colony screening, and genotype quality control before behavioral, inflammatory, and autophagy analyses.

• Verteporfin in YAP–TEAD Lineage Assays

  2026-08-18

  Verteporfin (CL 318952) is best known for photodynamic therapy, but its context-dependent effects can also inform lineage and enhancer-state assays. This article presents a rigorous framework for separating photosensitization, apoptosis, autophagy inhibition, and YAP–TEAD-linked developmental phenotypes.

• ARCA Cy5 EGFP mRNA: Assay Design Guide

  2026-08-18

  Learn how ARCA Cy5 EGFP mRNA (5-moUTP) separates cellular uptake, intracellular localization, endosomal escape, and protein expression in mammalian delivery studies. This guide integrates fluorescent readouts with the workflow principles of modern mRNA lipid nanoparticle characterization.

• DiscoveryProbe™ Metabolism-related Compound Library

  2026-08-17

  The DiscoveryProbe™ Metabolism-related Compound Library provides 493 pre-dissolved small molecules for organized metabolic enzyme, pathway, and cell-based screening workflows. It is intended for controlled in vitro and ex vivo research, not for diagnosis, treatment, clinical decision-making, or assumed in vivo efficacy.

• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-08-17

  α-Bungarotoxin is a high-affinity α7 nicotinic acetylcholine receptor antagonist used for nicotinic receptor blockade, cholinergic neurotransmission inhibition, and receptor-pharmacology studies. In a rat placental-ischemia model, α-bungarotoxin pharmacologically tested whether α7 signaling was required for pyridostigmine-associated protection, but the finding does not establish a clinical treatment or a universal α7-specific effect.

• Hsa_circ_0001944, FXR/TLR4, and Ferroptosis

  2026-08-16

  The 2025 Toxics study identifies hsa_circ_0001944 as a regulatory link between FXR/TLR4 signaling, ferroptosis, and nickel oxide nanoparticle-induced collagen formation in LX-2 hepatic stellate cells. Its pharmacological and genetic experiments suggest that restoring this circular RNA or activating FXR can reduce profibrotic responses, while also highlighting important limits for translating cell-model findings into broader metabolic or therapeutic conclusions.

• Firefly Luciferase mRNA as a Translational Benchmark

  2026-08-15

  A mechanistic and strategic guide to using Cap1, 5-moUTP, and poly(A) design to evaluate mRNA delivery, translation, and translational readiness with a firefly luciferase reporter.

• Phosbind Biotin LC: Practical Phosphoprotein Detection

  2026-08-14

  Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes when a suitable phospho-specific antibody is unavailable or insufficient. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of working solutions.

• ACE Inhibitor Selectivity Across Aminopeptidases

  2026-08-14

  Tieku and Hooper re-evaluated the selectivity of bestatin and several metallopeptidase inhibitors against three porcine kidney cell-surface aminopeptidases. Their comparative analysis showed that inhibitor behavior varied substantially among aminopeptidase A, N, and W, providing an important framework for interpreting off-target activity in ACE inhibitor and peptide-metabolism studies.

• Pyridostigmine, α7nAChR, and Placental Necroptosis

  2026-08-13

  This study identifies placental necroptosis as a modifiable component of placental ischemia in a rat model of preeclampsia-like disease. Its antagonist and inhibitor experiments suggest that pyridostigmine acts through α7 nicotinic acetylcholine receptor signaling to reduce necroptosis, inflammation, oxidative stress, and maternal hypertension.

• LEE011 Succinate: A Mechanism-First Assay Guide

  2026-08-13

  Explore LEE011 succinate as a CDK inhibitor through a mechanism-first framework for cell cycle regulation and cancer research. This guide connects target engagement, orthogonal phenotyping, formulation variables, and insights from an EV71 antiviral study without conflating distinct biological mechanisms.

• Linoleic Acid–PPARα–TF Signaling in pLELC

  2026-08-12

  This reference study combines proteomics, metabolomics, functional perturbation, and patient-derived xenograft validation to identify a linoleic acid–PPARα–tissue factor axis in primary pulmonary lymphoepithelioma-like carcinoma. The findings connect altered lipid handling with immune-cell remodeling and support tissue factor as a candidate therapeutic target, while also defining important limits for translating the mechanism into other PPARα research settings.

8112 records 8/541 page Previous Next First page 上5页 678910 下5页 Last page